The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 02, 2025
Filed:
Dec. 10, 2020
Applicant:
Chiesi Farmaceutici S.p.a., Parma, IT;
Inventors:
Gabriele Amari, Parma, IT;
Elisabetta Armani, Parma, IT;
Mafalda Pagano, Parma, IT;
Luca Raveglia, Parma, IT;
Marta Giuliani, Parma, IT;
Claudia Beato, Parma, IT;
Assignee:
Chiesi Farmaceutici S.p.A., Parma, IT;
Primary Examiner:
Int. Cl.
CPC ...
C07D 417/12 (2006.01); C07D 239/94 (2006.01); C07D 409/12 (2006.01); C07D 413/12 (2006.01); C07D 413/14 (2006.01); C07D 417/14 (2006.01);
U.S. Cl.
CPC ...
C07D 417/12 (2013.01); C07D 239/94 (2013.01); C07D 409/12 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01);
Abstract
The present invention relates to a compounds of general formula (I) inhibiting lysophosphatidic acid receptor 2 (LPA2), particularly the invention relates to compounds that are quinazoline derivatives, methods of preparing such compounds, pharmaceutical compositions containing them and therapeutic use thereof. The compounds of the invention may be useful in the treatment of diseases or conditions associated with a dysregulation of LPA receptors, in particular fibrosis.